In an effort to provide cost-effective training to the broadest group possible, I am launching a series of webinars in the upcoming months. The first of these will be in early February, and the goal will be to help grantees recognize and correct common submission mistakes. Unlike many who conduct NIH submission training programs, I myself work […]
New Webinar: “Mistakes Commonly Made on NIH Grant Applications” Read More »
We are happy to announce that in addition to one-on-one consulting, workshops, and seminars, we are now adding webinars to our menu of options to help NIH grantees. Upcoming webinars: Mistakes Commonly Made On NIH Grant Applications Benefit from the knowledge gained by a grantwriter who reads dozens of Summary Statements per year. Wednesday 4
NIH Grantwriting Webinar Series Begins in February 2015! Read More »
Remember ketamine, the old veterinary (and sometimes street) drug? Apparently it rapidly and significantly reduces anhedonia in those with treatment-resistant bipolar disorder, according to a new study. Anhedonia, which is a lack of interest in activities that once gave a person pleasure, is a key feature of treatment-resistant bipolar disorder. According to a recent NIH-funded
Ketamine — A New Drug Treatment For Depression? Read More »
